DAFNA Capital Management LLC
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationlos angeles, CA
- CIK0001389933
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
82 | $393.41M | KRE, RJR1, RVMD, ATRC | 13F-HR | Feb 14, 2025 | 000138993225000004 | ||
84 | $423.31M | KRE, RJR1, RVMD, CYTK | 13F-HR | Nov 14, 2024 | 000138993224000020 | ||
83 | $418.57M | KRE, RJR1, MERUS N V, CYTK | 13F-HR | Aug 14, 2024 | 000138993224000016 | ||
72 | $439.28M | KRE, RJR1, CYTK, IDYA | 13F-HR | May 15, 2024 | 000138993224000012 | ||
76 | $417.34M | KRE, CYTK, RJR1, IDYA | 13F-HR | Feb 14, 2024 | 000138993224000004 | ||
75 | $321.49M | KRE, RJR1, CYTK, IDYA | 13F-HR | Nov 14, 2023 | 000138993223000010 | ||
73 | $365.73M | KRE, ISEE, RJR1, BPMC | 13F-HR | Aug 14, 2023 | 000138993323000008 | ||
72 | $333.54M | KRE, RJR1, ISEE, ASND | 13F-HR | May 15, 2023 | 000138993323000006 | ||
79 | $355.06M | KRE, RJR1, ASND, KRTX | 13F-HR | Feb 14, 2023 | 000138993323000002 | ||
87 | $371.81M | KRE, RJR1, BPMC, BIOHAVEN PHARMACTL HLDG CO L | 13F-HR | Nov 14, 2022 | 000138993322000010 | ||
90 | $366.90M | KRE, RJR1, BIOHAVEN PHARMACTL HLDG CO L, ACET | 13F-HR | Aug 15, 2022 | 000138993322000008 | ||
94 | $383.78M | RJR1, KRE, FATE, BPMC | 13F-HR | May 16, 2022 | 000138993322000006 | ||
87 | $397.68M | RJR1, BPMC, FATE, ACET | 13F-HR | Feb 14, 2022 | 000138993322000002 | ||
80 | $376.92M | RJR1, BPMC, FATE, BIOHAVEN PHARMACTL HLDG CO L | 13F-HR | Nov 15, 2021 | 000138993321000011 | ||
84 | $478.15M | RJR1, FATE, DRNA, BPMC | 13F-HR | Aug 16, 2021 | 000138993321000009 | ||
89 | $421.48M | RJR1, FATE, BPMC, DRNA | 13F-HR | May 17, 2021 | 000138993321000007 | ||
74 | $336.08M | RJR1, FATE, BPMC, SAGE | 13F-HR | Feb 16, 2021 | 000138993321000004 | ||
80 | $307.63M | RJR1, IMMU, BPMC, FATE | 13F-HR | Nov 16, 2020 | 000138993320000010 | ||
87 | $346.51M | RJR1, BPMC, FATE, ARNA | 13F-HR | Aug 14, 2020 | 000138993320000008 | ||
80 | $239.63M | RJR1, BPMC, FATE, GLPG | 13F-HR | May 15, 2020 | 000138993320000006 | ||
81 | $291.33M | RJR1, PROQR THRAPEUTICS N V, ATRC, AQL | 13F-HR | Feb 14, 2020 | 000138993320000004 | ||
89 | $265.90M | RJR1, SAGE, ALDR, BPMC | 13F-HR | Nov 14, 2019 | 000138993319000010 | ||
87 | $266.03M | RJR1, SAGE, BPMC, ATRC | 13F-HR | Aug 14, 2019 | 000138993319000008 | ||
79 | $231.80M | RJR1, SAGE, BPMC, ATRC | 13F-HR | May 15, 2019 | 000138993319000006 | ||
83 | $201.09M | LOXO, RJR1, SAGE, ATRC | 13F-HR | Feb 14, 2019 | 000138993319000002 | ||
75 | $243.52M | LOXO, RJR1, SAGE, ATRC | 13F-HR | Nov 14, 2018 | 000138993318000012 | ||
75 | $213.58M | LOXO, SAGE, RJR1, AERIE PHARMACEUTICALS INC | 13F-HR | Aug 13, 2018 | 000138993318000010 | ||
75 | $205.56M | LOXO, SAGE, RJR1, BPMC | 13F-HR | May 15, 2018 | 000138993318000008 | ||
72 | $185.69M | LOXO, BPMC, ATRC, AERIE PHARMACEUTICALS INC | 13F-HR | Feb 14, 2018 | 000138993318000002 | ||
73 | $161.05M | LOXO, ATRC, BGNE, IMMU | 13F-HR | Nov 14, 2017 | 000138993317000025 | ||
75 | $140.14M | LOXO, ATRC, IMMU, AERIE PHARMACEUTICALS INC | 13F-HR | Aug 14, 2017 | 000138993317000023 | ||
72 | $118.23M | LOXO, ATRC, NXTM, ALDR | 13F-HR | May 15, 2017 | 000138993317000018 | ||
66 | $113.82M | ATRC, NXTM, ALDR, LOXO | 13F-HR | Feb 14, 2017 | 000138993317000014 | ||
74 | $143.58M | VTAE, 2032744D, ATRC, NXTM | 13F-HR | Nov 14, 2016 | 000138993316000037 | ||
94 | $126.17M | NXTM, ATRC, VTAE, 1934798D | 13F-HR | Aug 15, 2016 | 000138993316000031 | ||
93 | $115.93M | ATRC, ABBV, NXTM, VTAE | 13F-HR | May 16, 2016 | 000138993316000029 | ||
77 | $112.18M | ATRC, NXTM, ABBV, MRNS | 13F-HR | Feb 12, 2016 | 000138993316000022 | ||
88 | $100.78M | ATRC, ABBV, NXTM, ZSPH | 13F-HR | Nov 13, 2015 | 000138993315000019 | ||
75 | $118.24M | ATRC, ABBV, NXTM, 1893407D | 13F-HR | Aug 14, 2015 | 000138993315000016 | ||
71 | $130.25M | PCYC, ATRC, ASPX, NXTM | 13F-HR | May 15, 2015 | 000138993315000013 | ||
62 | $126.41M | PCYC, ATRC, ASPX, NXTM | 13F-HR | Feb 17, 2015 | 000138993315000009 | ||
59 | $99.15M | PCYC, DYBN, ATRC, NXTM | 13F-HR | Nov 14, 2014 | 000138993314000012 | ||
49 | $105.52M | APH, ATRC, PCYC, DYBN | 13F-HR | Aug 14, 2014 | 000138993314000010 | ||
46 | $116.35M | DYBN, PCYC, ATRC, APH | 13F-HR | May 15, 2014 | 000138993314000008 | ||
47 | $97.16M | DYBN, PCYC, ATRC, RJR1 | 13F-HR | Feb 14, 2014 | 000138993314000001 |